Français

Acasti Pharma Inc.

  • English
  • About Us
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • CaPre®
    • TRILOGY Phase 3
    • Partnering
  • Our Science
  • News & Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Results
    • Stock Data
    • Regulatory Filings
    • Governance
  • Contact
  • Français

Press Releases

News & Investors

News & Investors

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Media
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Contacts
    • FAQ
  • Financial Results
  • Stock Data
    • NASDAQ: ACST
    • TSXV: ACST
    • Analyst Coverage
  • Regulatory Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Section 16 Filings
    • SEDAR
  • Governance
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • Overview
  • Press Releases
  • Media
  • IR Calendar
  • Email Alerts

Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021

Aug 13, 2020

Acasti Pharma Submits Statistical Analysis Plan to FDA and Remains On Track to Report TRILOGY 2 Topline Data On or About August 31, 2020

Jul 31, 2020

Acasti Pharma Provides Fiscal 2020 Year-End Business Update

Jun 29, 2020

Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package

Jun 19, 2020

Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA

Apr 30, 2020

Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada

Apr 20, 2020

Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June

Apr 1, 2020

Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico

Mar 11, 2020

Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements

Feb 28, 2020

Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020

Feb 14, 2020
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...20
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
    © 2021 Acasti Pharma Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap